Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
Current studies that compare the efficacy and safety of micafungin (MCFG) with that of triazoles for the prophylaxis and treatment of invasive fungal infections (IFIs) demonstrate a lack of sufficient evidence and yield conflicting results. To compare the efficacy and safety of MCFG and triazoles in...
Main Authors: | Cho-Hao Lee, Jung-Chung Lin, Ching-Liang Ho, Min Sun, Wel-Ting Yen, Chin Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5507498?pdf=render |
Similar Items
-
Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada
by: Amir A Tahami Monfared, et al.
Published: (2012-01-01) -
Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study
by: Maria Kotsopoulou, et al.
Published: (2019-02-01) -
Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01) -
Prophylaxis of Invasive Fungal Infection in Patients with Neutropenia Related to Chemotherapy or Hematologic Stem Cell Transplantation
by: Ya-Lien Huang, et al.
Published: (2012) -
Micafungin Compared with Caspofungin for the Treatment of Febrile Episodes in Neutropenic Patients with Hematological Malignancies: A Retrospective Study
by: Sarah Shalhoub, et al.
Published: (2014-01-01)